A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Public ClinicalTrials.gov record NCT02395549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02395549
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Mimetica Pty Limited
- Industry
- Enrollment
- 364 participants
Conditions and interventions
Conditions
Interventions
- 0.375% (w/w) MTC896 Gel Drug
- 0.75% (w/w) MTC896 Gel Drug
- 1.5% (w/w) MTC896 Gel Drug
- Vehicle Control Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2015
- Primary completion
- May 31, 2016
- Completion
- Jul 31, 2016
- Last update posted
- Jun 15, 2016
2015 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Sanford | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Warren | Michigan | — | — |
| Not listed | Minneapolis | Minnesota | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Hershey | Pennsylvania | — | — |
| Not listed | Johnston | Rhode Island | — | — |
| Not listed | Warwick | Rhode Island | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | College Station | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02395549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02395549 live on ClinicalTrials.gov.